Atlas Trials

Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects

Clinical trial NCT00706797 · TERMINATED

Trial details

NCT number
NCT00706797
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2008-09-01
Primary completion
2009-12-01
Enrollment
141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.